Association of Centre of Excellence Self- Administered Questionnaire Score and Frailty Levels

Frailty Clinical Trial

Official title:

Association of Centre of Excellence Self-Administered Questionnaire (CESAM) Score and Frailty Levels With Incident Health Adverse Events in Older Community Dwellers: Results of the Canadian Longitudinal Study on Aging

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT03991806
• Other study ID #: 2020-1844
• Status: Active, not recruiting
• Start date: May 31, 2020
• Est. completion date: August 31, 2025

Study information

• Verified date: February 2024
• Source: Jewish General Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

This study evaluates the frailty and the health adverse events in the population of the Canadian Longitudinal Study on Aging. It will be used the Centre of Excellence Self-Administered questionnaire (CESAM) which assesses frailty of older adults by providing a score and a of frailty in 4 levels.

Description:

Age is broadly recognized to confer a risk for health adverse outcomes, but it is an insensitive and non-specific measure for use in individual decision-making. Frailty has been emerging to take its rightful place as a better measure for over past decades. Despite general consensus that the concept of frailty is clinically useful, the lack of agreement on its definition and the challenge of its measurement by front-line health providers mean that frailty remains only 'their apparent' to chronological age as a criterion to select older persons at risk.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 30000
• Est. completion date: August 31, 2025
• Est. primary completion date: December 31, 2024
• Accepts healthy volunteers: No
• Gender: All
• Age group: 65 Years and older

Eligibility

Inclusion Criteria:

• Being 65 years and over

• Being enrolled in the Canadian Longitudinal Study on Aging

Exclusion Criteria:

• Never being enrolled in the Canadian Longitudinal Study on Aging

• Undisclosed health adverse events

Related Conditions & MeSH terms

• Cognitive Decline
• Cognitive Dysfunction
• Fall Injury
• Frailty
• Injuries
• Wounds and Injuries

Intervention

Other:
• Obsservational
The frailty and the health adverse events of older adults will be assessed by using a questionnaire called: Association of Centre of Excellence Self-Administered questionnaire (CESAM).

Locations

Country	Name	City	State
Canada	Jewish General Hospital	Montréal	Quebec

Sponsors (1)

Lead Sponsor	Collaborator
Jewish General Hospital

Country where clinical trial is conducted

Canada, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Dementia	The algorithm is a three- step process involving administration of the neuropsychological battery to develop composite score in the three domains-memory, executive function, and psychomotor speed.; The primary outcome of the study will be to determine the number of participants to whom the memory, the executive function, and the psychomotor speed are affected.	around 18 months
Secondary	Medication	In the maintaining contact interview, one question will be asked of all participants in relation to prescription medication use in the preceding month. A second question asks about the frequency of prescription drug use during this month.; The secondary outcome of the study will be to determine the number of the medication that the participant take during a period of time.	around 18 months